Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Cited by (1,077)

Items 601–700 of 1,077

1. World Journal of Pharmaceutical Sciences
   2021 · World Journal of Pharmaceutical Sciences
2. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica
   Randy Mellaerts, Raf Mols, Jasper A. G. Jammaer, Caroline A. Aerts, Pieter Annaert, Jan Van Humbeeck, Guy Van den Mooter, Patrick Augustijns, Johan A. Martens · 2007 · European Journal of Pharmaceutics and Biopharmaceutics
3. Asparagine Synthetase Chemotherapy
   Nigel G. J. Richards, Michael S. Kilberg · 2006 · Annual Review of Biochemistry
4. MODELING OF INTESTINAL DRUG ABSORPTION: ROLES OF TRANSPORTERS AND METABOLIC ENZYMES (FOR THE GILLETTE REVIEW SERIES)
   K. Sandy Pang · 2003 · Drug Metabolism and Disposition
5. DNA-Encoded Chemical Libraries: Advancing beyond Conventional Small-Molecule Libraries
   Raphael M. Franzini, Dario Neri, Jörg Scheuermann · 2014 · Accounts of Chemical Research
6. Unraveling the Role of Linker Design in Proteolysis Targeting Chimeras
   Troy A. Bemis, James J. La Clair, Michael D. Burkart · 2021 · Journal of Medicinal Chemistry
7. Nucleic acid delivery with chitosan and its derivatives
   Wing‐Fu Lai, Marie C.M. Lin · 2008 · Journal of Controlled Release
8. Can we estimate the accuracy of ADME–Tox predictions?
   Igor V. Tetko, Pierre Bruneau, Hans‐Werner Mewes, Douglas C. Rohrer, Gennadiy I. Poda · 2006 · Drug Discovery Today
9. Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes
   Emmanuelle Lautié, Olivier Russo, Pierre Ducrot, Jean Albert Boutin · 2020 · Frontiers in Pharmacology
10. Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
    Thomas R. Ioerger, Theresa O’Malley, Reiling Liao, Kristine M. Guinn, Mark J. Hickey, Nilofar Mohaideen, Kenan C. Murphy, Helena I. Boshoff, Valerie Mizrahi, Eric J. Rubin et al. · 2013 · PLoS ONE
11. Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs.
    Grzegorz Grynkiewicz, Maria Gadzikowska · 2008 · PubMed
12. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo
    Michael Linn, Eva-Maria Collnot, Dejan Djurić, Katja Hempel, Eric J. Fabian, Karl Kolter, Claus‐Michael Lehr · 2011 · European Journal of Pharmaceutical Sciences
13. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration
    Ewart T. Cole, Dominique Cadé, Hassan Benameur · 2007 · Advanced Drug Delivery Reviews
14. How to explore chemical space using algorithms and automation
    Piotr S. Gromski, Alon Henson, Jarosław M. Granda, Leroy Cronin · 2019 · Nature Reviews Chemistry
15. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview
    Sounak Bagchi, Tanya Chhibber, Behnaz Lahooti, Angela Verma, Vivek B. Borse, Rahul Dev Jayant · 2019 · Drug Design Development and Therapy
16. Critical review of the role of HTS in drug discovery
    Ricardo Macarrón · 2006 · Drug Discovery Today
17. Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders
    Hughes, Scott J., Ciulli, Alessio · 2017 · Essays in Biochemistry
18. Binding Site Detection and Druggability Index from First Principles
    Jesús Seco, Francisco Javier Luque, Xavier Barril · 2009 · Journal of Medicinal Chemistry
19. Getting Drugs Across Biological Barriers
    Rong Yang, Tuo Wei, Hannah Goldberg, Weiping Wang, Kathleen Cullion, Daniel S. Kohane · 2017 · Advanced Materials
20. Physicochemical Properties of Pharmaceutical Co-Crystals: A Case Study of Ten AMG 517 Co-Crystals
    Mary K. Stanton, Annette Bak · 2008 · Crystal Growth & Design
21. Experiences in fragment-based drug discovery
    Christopher W. Murray, Marcel L. Verdonk, David C. Rees · 2012 · Trends in Pharmacological Sciences
22. ADME/PK as part of a rational approach to drug discovery
    Peter J. Eddershaw, Alan P. Beresford, Martin K. Bayliss · 2000 · Drug Discovery Today
23. Pharmaceutical Technologies for Enhancing Oral Bioavailability of Poorly Soluble Drugs
    Yellela S.R. Krishnaiah · 2010 · Journal of Bioequivalence & Bioavailability
24. Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
    Jay H. Kalin, Muzhou Wu, Andrea V. Gómez, Yun Song, Jayanta Das, Dawn Hayward, Nkosi Adejola, Mingxuan Wu, Izabela P. Panova, Hye Jin Chung et al. · 2018 · Nature Communications
25. Let’s not forget tautomers.
    Martin, Yvonne Connolly · 2009 · Journal of Computer-Aided Molecular Design
26. Prediction of Aqueous Solubility of a Diverse Set of Compounds Using Quantitative Structure−Property Relationships
    Ailan Cheng, Kenneth M. Merz · 2003 · Journal of Medicinal Chemistry
27. Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling
    Linlin Zhao, Heather L. Ciallella, Lauren M. Aleksunes, Hao Zhu · 2020 · Drug Discovery Today
28. PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation
    Kariem Ezzat, Samir EL Andaloussi, Eman M. Zaghloul, Taavi Lehto, Staffan Lindberg, Pedro M. D. Moreno, Joana R. Viola, Tarek Magdy, Rania Abdo, Peter Guterstam et al. · 2011 · Nucleic Acids Research
29. AfroDb: A Select Highly Potent and Diverse Natural Product Library from African Medicinal Plants
    Fidele Ntie‐Kang, Dénis Zofou, Smith Borakaeyabe Babiaka, Rolande Meudom, Michael Scharfe, Lydia Likowo Lifongo, James A. Mbah, Luc Mbaze Meva’à, Wolfgang Sippl, Simon M. N. Efange · 2013 · PLoS ONE
30. Solid Dispersion as an Approach for Bioavailability Enhancement of Poorly Water-Soluble Drug Ritonavir
    Shilpi Sinha, Mushir Ali, Sanjula Baboota, Alka Ahuja, Anil Kumar, Javed Ali · 2010 · AAPS PharmSciTech
31. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5
    Gislaine Kuminek, Fengjuan Cao, Alanny Bahia de Oliveira da Rocha, Simone Gonçalves Cardoso, Naír Rodríguez‐Hornedo · 2016 · Advanced Drug Delivery Reviews
32. Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five
    Caroline Manto Chagas, Sara Moss, Laleh Alisaraie · 2018 · International Journal of Pharmaceutics
33. In Vitro Models of the Intestinal Barrier
    Eric Le Ferrec, Christophe Chesné, Per Artusson, David J. Brayden, Gérard Fabre, Pierre Gires, François Guillou, Monique Rousset, Werner Rubas, Maria-Laura Scarino · 2001 · Alternatives to Laboratory Animals
34. The emerging importance of predictive ADME simulation in drug discovery
    Harold E. Selick, Alan P. Beresford, Michael H. Tarbit · 2002 · Drug Discovery Today
35. ADME Evaluation in Drug Discovery. 7. Prediction of Oral Absorption by Correlation and Classification
    Tingjun Hou, Junmei Wang, Wei Zhang, Xiaojie Xu · 2006 · Journal of Chemical Information and Modeling
36. RVX-208
    Dana Bailey, Ravi Jahagirdar, Allan Gordon, Anouar Hafiane, Steven Campbell, Safia Chatur, Gregory S. Wagner, Henrik Claus Hansen, Fabrizio S. Chiacchia, Jan Johansson et al. · 2010 · Journal of the American College of Cardiology
37. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials
    Randy Mellaerts, Caroline A. Aerts, Jan Van Humbeeck, Patrick Augustijns, Guy Van den Mooter, Johan A. Martens · 2007 · Chemical Communications
38. SureChEMBL: a large-scale, chemically annotated patent document database
    George Papadatos, Mark Davies, Nathan Dedman, Jon K. Chambers, Anna Gaulton, James Siddle, Richard Koks, Sean A. Irvine, Joe Pettersson, Nicko Goncharoff et al. · 2015 · Nucleic Acids Research
39. Multiple Independent Binding Sites for Small-Molecule Inhibitors on the Oncoprotein c-Myc
    Dalia I. Hammoudeh, Ariele Viacava Follis, Edward V. Prochownik, Steven J. Metallo · 2009 · Journal of the American Chemical Society
40. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: The ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats
    Arik Dahan, Amnon Hoffman · 2007 · European Journal of Pharmaceutics and Biopharmaceutics
41. The potential of anti-malarial compounds derived from African medicinal plants. Part I: A pharmacological evaluation of alkaloids and terpenoids
    Pascal Amoa Onguéné, Fidele Ntie‐Kang, Lydia Likowo Lifongo, Jean Claude Ndom, Wolfgang Sippl, Luc Mbaze Meva’à · 2013 · Malaria Journal
42. Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
    Ivanenkov, Yan A., Polykovskiy, Daniil, Bezrukov, Dmitry, Zagribelnyy, Bogdan, Aladinskiy, Vladimir, Kamya, Petrina, Aliper, Alex, Ren, Feng, Zhavoronkov, Alex · 2023 · Journal of Chemical Information and Modeling
43. Role of Nanotechnology in Pharmaceutical Product Development
    Harikrishna Devalapally, Ananthsrinivas R. Chakilam, Mansoor M. Amiji · 2007 · Journal of Pharmaceutical Sciences
44. Macrocyclic Drugs and Synthetic Methodologies toward Macrocycles
    Xufen Yu, Dianqing Sun · 2013 · Molecules
45. AlzPlatform: An Alzheimer’s Disease Domain-Specific Chemogenomics Knowledgebase for Polypharmacology and Target Identification Research
    Haibin Liu, Lirong Wang, Mingliang Lv, Rongrong Pei, Peibo Li, Zhong Pei, Yonggang Wang, Weiwei Su, Xiang‐Qun Xie · 2014 · Journal of Chemical Information and Modeling
46. Effect of Detergent on “Promiscuous” Inhibitors
    Ali J. Ryan, Norman M. Gray, Peter N. Lowe, Chun‐wa Chung · 2003 · Journal of Medicinal Chemistry
47. Structural Basis for Telomeric G-Quadruplex Targeting by Naphthalene Diimide Ligands
    Gavin W. Collie, Rossella Promontorio, Sonja M. Hampel, Marialuisa Micco, Stephen Neidle, Gary Nigel Parkinson · 2012 · Journal of the American Chemical Society
48. Dielectrophoresis for Biomedical Sciences Applications: A Review
    Nurhaslina Abd Rahman, Fatimah Ibrahim, Bashar Yafouz · 2017 · Sensors
49. Structural Biology and Drug Discovery of Difficult Targets: The Limits of Ligandability
    Surade, Sachin, Blundell, Tom L. · 2012 · Chemistry & Biology
50. Ligand-based targeted therapy for cancer tissue
    Manasi Das, Chandana Mohanty, Sanjeeb Kumar Sahoo · 2009 · Expert Opinion on Drug Delivery
51. Nanotechnology as Emerging Tool for Enhancing Solubility of Poorly Water-Soluble Drugs
    Sandeep Kumar, Neeraj Dilbaghi, Ruma Saharan, Gaurav Bhanjana · 2012 · BioNanoScience
52. Metabolism of Xenobiotics of Human Environments
    Edward L. Croom · 2012 · Progress in molecular biology and translational science
53. Kinase Inhibitors: Not Just for Kinases Anymore
    Susan Lynne McGovern, Brian K. Shoichet · 2003 · Journal of Medicinal Chemistry
54. Helping Chemists Discover New Antibiotics
    Mark A. T. Blaskovich, Johannes Zuegg, Alysha G. Elliott, Matthew A. Cooper · 2015 · ACS Infectious Diseases
55. Developing early formulations: Practice and perspective
    Ping Li, Luwei Zhao · 2007 · International Journal of Pharmaceutics
56. A Machine Learning-Based Method To Improve Docking Scoring Functions and Its Application to Drug Repurposing
    Sarah Kinnings, Nina Liu, Peter J. Tonge, Richard M. Jackson, Lei Xie, Philip E. Bourne · 2011 · Journal of Chemical Information and Modeling
57. Novel synthetic small‐molecule activators of AMPK as enhancers of autophagy and amyloid‐β peptide degradation
    Valérie Vingtdeux, Pallavi Chandakkar, Haitian Zhao, Cristina d’Abramo, Peter Davies, Philippe Marambaud · 2010 · The FASEB Journal
58. Use of the Biopharmaceutical Classification System in Early Drug Development
    M. Sherry Ku · 2008 · The AAPS Journal
59. Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases
    Alexander Schmitz, Ananthakrishnan Sankaranarayanan, Philippe Azam, Kristina Schmidt-Lassen, Daniel Homerick, Wolfram Hänsel, Heike Wulff · 2005 · Molecular Pharmacology
60. Chemical probes and drug leads from advances in synthetic planning and methodology
    Christopher J. Gerry, Stuart L. Schreiber · 2018 · Nature Reviews Drug Discovery
61. Present and future in vitro approaches for drug metabolism
    Sean Ekins, Barbara J. Ring, James E. Grace, Donna J. Belle, Steven A. Wrighton · 2000 · Journal of Pharmacological and Toxicological Methods
62. Antagonists of protein–protein interactions
    Andrea G. Cochran · 2000 · Chemistry & Biology
63. Interactive exploration of chemical space with Scaffold Hunter
    Stefan Wetzel, Karsten Klein, Steffen Renner, Daniel Rauh, Tudor Ionel Oprea, Petra Mutzel, Herbert Waldmann · 2009 · Nature Chemical Biology
64. Mesoporous Silica Nanoparticles for Increasing the Oral Bioavailability and Permeation of Poorly Water Soluble Drugs
    Yanzhuo Zhang, Jiancheng Wang, Xiaoyu Bai, Tongying Jiang, Qiang Zhang, Siling Wang · 2012 · Molecular Pharmaceutics
65. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic
    Sam Maher, Thomas W. Leonard, Jette Bredahl Jacobsen, David J. Brayden · 2009 · Advanced Drug Delivery Reviews
66. Prevention of Chronic Diseases by Tea: Possible Mechanisms and Human Relevance
    Chung Shu Yang, Jungil Hong · 2013 · Annual Review of Nutrition
67. ExCAPE-DB: an integrated large scale dataset facilitating Big Data analysis in chemogenomics
    Jiangming Sun, Nina Jeliazkova, Vladimir Chupakhin, José Felipe Golib Dzib, Ola Engkvist, Lars Carlsson, Jörg K. Wegner, Hugo Ceulemans, Ivan Georgiev, Vedrin Jeliazkov et al. · 2017 · Journal of Cheminformatics
68. A Radical Approach to Anionic Chemistry: Synthesis of Ketones, Alcohols, and Amines
    Shengyang Ni, Natalia M. Padial, Cian Kingston, Julien C. Vantourout, Daniel C. Schmitt, Jacob T. Edwards, Monika M. Kruszyk, Rohan R. Merchant, Pavel K. Mykhailiuk, Brittany B. Sanchez et al. · 2019 · Journal of the American Chemical Society
69. Learning Molecular Representations for Medicinal Chemistry
    Kangway V. Chuang, Laura M. Gunsalus, Michael J. Keiser · 2020 · Journal of Medicinal Chemistry
70. Review and analysis of FDA approved drugs using lipid-based formulations
    Savla, Ronak, Browne, Jeff, Plassat, Vincent, Wasan, Kishor M., Wasan, Ellen K. · 2017 · Drug Development and Industrial Pharmacy
71. SYNOPSIS: SYNthesize and OPtimize System in Silico
    H. Maarten Vinkers, Marc R. de Jonge, Frederik F. D. Daeyaert, Jan Heeres, Lucien M. H. Koymans, Joop H. van Lenthe, Paul J Lewi, Henk Timmerman, Koen Van Aken, Paul A. J. Janssen · 2003 · Journal of Medicinal Chemistry
72. Chemoinformatics and Drug Discovery
    Jun Chen Xu, A. T. Hagler · 2002 · Molecules
73. What can a chemist learn from nature?s macrocycles? ? A brief, conceptual view
    Ludger A. Wessjohann, Eelco Ruijter, Daniel G. Rivera, Wolfganf Brandt · 2005 · Molecular Diversity
74. Strategies for Absorption Screening in Drug Discovery and Development
    Hilde Bohets, Pieter Annaert, Geert Mannens, Ludy van Beijsterveldt, Katelijne Anciaux, Peter Verboven, W. Meuldermans, Karel Lavrijsen · 2001 · Current Topics in Medicinal Chemistry
75. The solubility–permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone
    Dahan, Arik, Miller, Jonathan M., Hoffman, Amnon, Amidon, Gregory E., Amidon, Gordon L. · 2010 · Journal of Pharmaceutical Sciences
76. Chemical approaches to the discovery and development of cancer therapies
    Stephen Neidle, David E. Thurston · 2005 · Nature reviews. Cancer
77. Sustainable from the very beginning: rational design of molecules by life cycle engineering as an important approach for green pharmacy and green chemistry
    Klaus Kümmerer · 2007 · Green Chemistry
78. Transformer neural network for protein-specific de novo drug generation as a machine translation problem
    Daria Grechishnikova · 2021 · Scientific Reports
79. Natural product drug discovery in the artificial intelligence era
    Fernanda I. Saldívar‐González, Victor Daniel Aldas-Bulos, José L. Medina‐Franco, Fabien Plisson · 2021 · Chemical Science
80. Comparison of Electrospun and Extruded Soluplus®-Based Solid Dosage Forms of Improved Dissolution
    Zsombor Kristóf Nagy, Attila Balogh, Balázs Vajna, Attila Farkas, Gergő Patyi, Áron Kramarics, György Marosi · 2011 · Journal of Pharmaceutical Sciences
81. Ligand Pose and Orientational Sampling in Molecular Docking
    Ryan G. Coleman, Michael Carchia, Teague Sterling, John J. Irwin, Brian K. Shoichet · 2013 · PLoS ONE
82. Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking
    Klaus Hellmuth, Stefanie Grosskopf, Ching Tung Lum, Martin Würtele, Nadine Röder, Jens Peter von Kries, Marta Rosário, Jörg Rademann, Walter Birchmeier · 2008 · Proceedings of the National Academy of Sciences
83. Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes
    Sandy Ong, Long Chiau Ming, Kah Lee, Kah Hay Yuen · 2016 · Pharmaceutics
84. Generating Multibillion Chemical Space of Readily Accessible Screening Compounds
    Oleksandr O. Grygorenko, Dmytro S. Radchenko, Igor Dziuba, Alexander Chuprina, K.E. Gubina, Yurii S. Moroz · 2020 · iScience
85. Getting in Shape: Controlling Peptide Bioactivity and Bioavailability Using Conformational Constraints
    Jonathan E. Bock, Jason Gavenonis, Joshua A. Kritzer · 2012 · ACS Chemical Biology
86. Stoichiometry and Physical Chemistry of Promiscuous Aggregate-Based Inhibitors
    Kristin E. D. Coan, Brian K. Shoichet · 2008 · Journal of the American Chemical Society
87. Cancer Preventive Activities of Tea Catechins
    Chung Shu Yang, Hong Wang · 2016 · Molecules
88. NuBBEDB: an updated database to uncover chemical and biological information from Brazilian biodiversity
    Alan César Pilon, Marília Valli, Alessandra Cristina Dametto, Meri Emili F. Pinto, Rafael Teixeira Freire, Ian Castro‐Gamboa, Adriano Defini Andricopulo, Vanderlan da Silva Bolzani · 2017 · Scientific Reports
89. The Significance of G Protein-Coupled Receptor Crystallography for Drug Discovery
    John A. Salon, David T. Lodowski, Krzysztof Palczewski · 2011 · Pharmacological Reviews
90. Improving oral bioavailability of cyclic peptides by N-methylation
    Andreas F. B. Räder, Florian Reichart, Michael Weinmüller, Horst Kessler · 2017 · Bioorganic & Medicinal Chemistry
91. Inhibitors of SARS-CoV‑2 Entry: Current and Future Opportunities
    Siyu Xiu, Alexej Dick, Han Ju, Sako Mirzaie, Fatemeh Abdi, Simon Cocklin, Peng Zhan, Xinyong Liu · 2020 · Journal of Medicinal Chemistry
92. The Co‐Crystal Approach to Improve the Exposure of a Water‐Insoluble Compound: AMG 517 Sorbic Acid Co‐Crystal Characterization and Pharmacokinetics
    Annette Bak, Anu Gore, Evelyn Yanez, Mary K. Stanton, Sunita Tufekcic, Rashid S. Syed, Anna Akrami, Mark J. Rose, Sekhar Surapaneni, Tracy M. Bostick et al. · 2008 · Journal of Pharmaceutical Sciences
93. Scaffold diversity of natural products: inspiration for combinatorial library design
    Kristina Grabowski, Karl H. Baringhaus, Gisbert Schneider · 2008 · Natural Product Reports
94. Compilation of 222 drugs’ plasma protein binding data and guidance for study designs
    Fengling Zhang, Jinpin Xue, Jingwei Shao, Jia Li · 2011 · Drug Discovery Today
95. Specific Small Molecule Inhibitors of Skp2-Mediated p27 Degradation
    Lily I. Wu, A. V. Grigoryan, Yunfeng Li, Bing Hao, Michele Pagano, Timothy J. Cardozo · 2012 · Chemistry & Biology
96. Design of a small molecule against an oncogenic noncoding RNA
    Sai Pradeep Velagapudi, Michael D. Cameron, Christopher L. Haga, Laura H. Rosenberg, Marie Lafitte, Derek R. Duckett, Donald G. Phinney, Matthew David Disney · 2016 · Proceedings of the National Academy of Sciences
97. Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation
    Dawei Cai, Courtney Mills, Wenquan Yu, Ran Yan, Carol E. Aldrich, Jeffry R. Saputelli, William S. Mason, Xiaodong Xu, Ju‐Tao Guo, Timothy M. Block et al. · 2012 · Antimicrobial Agents and Chemotherapy
98. Synthesis, anticancer activity and mechanism of action of new thiazole derivatives
    Temístocles Ítalo de Santana, Míria de Oliveira Barbosa, Paulo André Teixeira de Moraes Gomes, Anne Cecília Nascimento da Cruz, Teresinha Gonçalves da Silva, Ana Cristina Lima Leite · 2017 · European Journal of Medicinal Chemistry
99. Overcoming Challenges in Small-Molecule Drug Bioavailability: A Review of Key Factors and Approaches
    Ke Wu, Soon Hwan Kwon, Xuhan Zhou, Claire Fuller, Xianyi Wang, Jaydutt V. Vadgama, Yong Wu · 2024 · International Journal of Molecular Sciences
100. Stability and Solubility of Celecoxib-PVP Amorphous Dispersions: A Molecular Perspective
     Piyush Gupta, Vasu Kumar Kakumanu, Arvind K. Bansal · 2004 · Pharmaceutical Research